Methylarginine - OmicsDI

Show results for

Unknown (58)
Genomics (15)
Proteomics (14)
Transcriptomics (12)
Metabolomics (7)
Models (4)

Organisms

Homo sapiens (15)
Alphavirus (14)
Archaea (14)
Bacteria (14)
Betaherpesvirinae (14)
Borrelia (14)
Botrytis cinerea (14)
Candida albicans (14)
Clostridium perfringens (14)
Eukaryota (14)
Fungi (14)
Hepatitis B virus (14)
Herpesvirales (14)
Human betaherpesvirus 5 (14)
Influenza A virus (14)
Influenza C virus (14)
Japanese encephalitis virus group (14)
Mammarenavirus (14)
Miscanthus x giganteus (14)
Mycobacterium tuberculosis (14)
Orthoflavivirus (14)
Panicum virgatum (14)
Rattus (14)
Saccharomyces cerevisiae (14)
Schizosaccharomyces (14)
Schizosaccharomyces pombe (14)
Severe acute respiratory syndrome coronavirus 2 (14)
Staphylococcus aureus (14)
Streptococcus pneumoniae (14)
Mus musculus (5)

Organisms

Homo sapiens (7)
Mus musculus (4)

Repository

pride (14)
geo (11)
ENA (11)
MetabolomicsWorkbench (6)
biostudies-arrayexpress (5)
BioModels (4)
MetaboLights (1)

Tissue

Binucleate cell (2)
Cell culture (2)
Colon (2)
Permanent cell line cell (2)
Trophozoite (2)
Kidney (1)
Macrophages (1)
Muscle (1)
Worms (1)
Liver (1)
Blood (1)
Epithelial cell (1)

Disease

Colon cancer (2)
Giardiasis (2)
Sarcopenia (1)
Chronic kidney disease (1)

Technology Type

Mass Spectrometry (20)
ESI (6)
Affinity purification coupled with mass spectrometry proteomics (5)
Shotgun proteomics (5)
Bottom-up proteomics (2)
Data-dependent acquisition (2)
Mass spectrometry (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Gel-based experiment (1)

Instrument Platform

Liquid Chromatography MS - - - Gas Chromatography MS - positive (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2025 (5)
2024 (5)
2005 (4)
2011 (4)
2020 (4)
2021 (3)
2012 (2)
2022 (2)
2016 (1)
2009 (1)
2023 (1)
2018 (1)
2026 (1)
2017 (1)

Metabolite Name

N-Dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate (1)
Pentasine (1)
Pentadeca-3,5,7-trienedioylcarnitine (1)
1-Naphthalenesulfonic acid, 4-hydroxy-3-nitroso- (1)
1-[5-(2-Cyclopropyl-5,7-dimethylimidazo[4,5-b]pyridin-3-ylmethyl)thiophen-2-yl]cyclopent-3-ene carboxylic acid (1)
SM(d18:1/24:2(5Z,9Z)) (1)
Farglitazar (1)
DG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0) (1)
2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol (1)
L-3-Amino-2-(oxalylamino)propanoic acid (1)
Kitagine (1)
Hydrazinecarbothioamide,2-[2-[2-(aminothioxomethyl)-2-methylhydrazinylidene]propylidene]-N-methyl- (1)
N-(2-Benzyl-3-((2-amino-4-methylpentyl)dithio)-1-oxopropyl)glycine benzyl ester (1)
Butanoic acid, 3-((2-naphthalenylsulfonyl)amino)-4-oxo-4-((2-phenylethyl)amino)-, (S)- (1)
(7'R*,8'S*)-Methyl 4,7'-epoxy-3,8'-bilign-7-ene-4',9'-dihydroxy-3',5-dimethoxy-9-oate (1)
Balsalazide (1)
Droxicam (1)
Sivelestat (1)
Thymine dimer (1)
4-Hydroxytoremifene (1)
Oleoyltaurine (1)
Teneligliptin (1)
SM(d18:1/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) (1)
Cefsulodin (1)
Furazabol (1)
Florfenicol amine (1)
(2S)-2-[[2-[(2S,3S)-2-[[(2R)-2-Amino-3-mercaptopropyl]amino]-3-methylpentoxy]-1-oxo-3-phenylpropyl]amino]-4-methylsulfonylbutanoic acid propan-2-yl ester (1)
3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide (1)
4'-Hydroxy Nimesulide (1)
Isoquinolinesulfonamide (1)

IsPrivate

False (4)

Model Flag

Non Miriam (4)

First Public Date

2025 (2)
2023 (2)
2021 (2)
2014 (2)
2022 (1)
2018 (1)
2013 (1)

Modelling Approach

Ordinary differential equation model (4)

Study type

ChIP-chip by tiling array (2)
ChIP-seq (1)
RNA-seq of coding RNA (1)
RNA-seq of non coding RNA (1)

Release Date

2020 (8)
2014 (6)
2012 (5)
2025 (5)
2021 (5)
2018 (5)
2024 (4)
2016 (3)
2011 (3)
2023 (3)
2010 (3)
2009 (2)
2022 (2)
2019 (2)
2013 (2)
2026 (1)
2017 (1)
2015 (1)
2005 (1)
2002 (1)

Lab affiliation

Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Melbourne, VIC, Australia (2)
1. Ministry of Education Key Laboratory of Biosystems Homeostasis & Protection, College of Life Sciences, Zhejiang University, Hangzhou, China 2. Cancer Center, Zhejiang University, Hangzhou, China (1)
Center for Teragnosis, biomedical research institute, Korea Institute of Science and Technology, Seoul, Korea (1)
Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC29425, USA (1)
Department of Surgery, Samsung Medical Center (1)
Developmental and Cell Biology University of California, Irvine Irvine, California, USA (1)
McGill University (1)
Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX (1)
SUN YAT-SEN UNIVERSITY (1)
School of Biotechnology and Biomolecular Sciences, University of New South Wales, NSW, Australia (1)
Systems Biology Initiative, School of Biotechnology and Biomolecular Sciences. (1)
UT-MDACC (1)
University of Copenhagen Faculty of Health and Medical Sciences Novo Nordisk Foundation Center for Protein Research Proteomics Program (1)

Previous page
1 / 11
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 11
Next page

Sort by:

Relevance

Page size

BRD9 functions as a methylarginine reader to regulate AKT-EZH2 signaling

Arginine methylation is a common posttranslational modification that is catalyzed by a family of protein arginine methyltransferases. Recognition of methylarginine marks by effector proteins (“readers”) is a critical link between arginine methylation and various cellular processes. We recently ident...

ORGANISM(S): Homo sapiens (Human)

2025-03-18 | PXD058540 | Pride